TherapeuticsMD, Inc. to Participate in Upcoming Investor Conferences
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced CEO Robert G. Finizio will provide an overview of the company at the following investor conferences:
- Jefferies 2015 Global Healthcare Conference, Tuesday, June 2 at 10 a.m. EDT at the Grand Hyatt New York in New York City
- Goldman Sachs 36th Annual Global Healthcare Conference, Tuesday, June 9 at 9:20 a.m. PDT at the Terranea Resort in Rancho Palos Verdes, Calif.
To listen to the live audio webcasts during the sessions, please visit the company's website, www.therapeuticsmd.com, and click the “Investor” tab. Replays of each webcast will be available on the company’s website for 30 days after the respective sessions.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its patented SYMBODA™ technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two phase 3 products. The company also manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter vitamins under the vitaMedMD® and BocaGreenMD® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150526005543/en/
TherapeuticsMD, Inc.
Dan Cartwright, 561-961-1900
Chief
Financial Officer
[email protected]
or
Julia
Amadio, 561-961-1900
Chief Product Officer
[email protected]
Source: TherapeuticsMD, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
- Watershed Roofing Inc. Expands Roofing and Exterior Services Across British Columbia
- FIA Celebrates Over Ninety Years of Supporting Motor Sport in the United States at the INDYCAR Freedom 250 Grand Prix of Washington D.C.
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Goldman Sachs, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share